Mean Nuclear Volume as a Prognostic Indicator in Prostatic Cancer
Author Information
Author(s): K Arima, Y Sugimura, T Hioki, A Yamashita, J Kawamura
Primary Institution: Mie University School of Medicine
Hypothesis
The study aims to determine if stereological estimation of mean nuclear volume (MNV) can provide a reliable and objective grading system for prostatic cancer.
Conclusion
Mean nuclear volume is a reliable predictor of survival in patients with prostatic cancer.
Supporting Evidence
- The study found a significant correlation between MNV and clinical stage.
- MNV was the only predictor of survival time in the multivariate analysis.
- Patients with a MNV below 257 μm3 had significantly better survival rates.
Takeaway
This study found that measuring the size of cancer cell nuclei can help doctors predict how long patients with prostate cancer might live.
Methodology
The study retrospectively analyzed clinical records and tissue specimens from 100 patients diagnosed with prostatic cancer, examining the relationship between MNV and clinical outcomes.
Potential Biases
Potential bias in histological grading due to subjective evaluation by pathologists.
Limitations
The study is retrospective and based on historical data, which may limit the applicability of the findings to current clinical practices.
Participant Demographics
Patients were newly diagnosed with prostatic cancer from 1973 to 1990, with a follow-up of 5 years or longer.
Statistical Information
P-Value
< 0.0001
Confidence Interval
1.003, 1.007
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website